Call Boomerang Books 1300 36 33 32

* This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).* Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.* The book integrates information from human and animal studies.* The book considers T1D within the broader context of autoimmune disease.* The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.

Buy Defining Optimal Immunotherapies for Type 1 Diabetes book by Novartis Foundation from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9780470723258
ISBN-10: 0470723254
Format: Hardback
(236mm x 163mm x 16mm)
Pages: 222
Imprint: Wiley-Blackwell
Publisher: John Wiley and Sons Ltd
Publish Date: 13-Jun-2008
Country of Publication: United States

Reviews

» Have you read this book? We'd like to know what you think about it - write a review about Defining Optimal Immunotherapies for Type 1 Diabetes book by Novartis Foundation and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review


Books By Author Novartis Foundation

Growth Factors and Psychiatric Disorders by Novartis Foundation

Growth Factors and Psychiatric Disorders

Hardback, February 2008
$284.36
Cortical Development by Novartis Foundation

Cortical Development

Hardback, January 2008
$284.36